We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Adults with type 2 diabetes, mild renal ...

While clinical guidelines call for those with diabetes to be tested regularly for kidney disease, less than 50% of these patients are tested once a year, according to the National Kidney Foundation.

Investigators have implemented an automated health maintenance tool created by the National Kidney Foundation into electronic medical records to prompt primary care physicians to screen for chronic ...

Renal cell carcinomas positive for the protein PD-L1 from patients who did not respond to treatment with the anti-PD-1 therapeutic nivolumab (Opdivo) had significantly higher expression of genes ...

Monitoring efficacy of neoadjuvant sunitinib in metastatic renal cell carcinoma using a personalized and tumor informed ctDNA assay. Targeted sequencing results of the five most frequently mutated ...

First Look at Data from Global SYMPLICITY Registry Shows Renal Denervation with the Symplicity(TM) System Meets Performance Expectations in Real-World Setting MINNEAPOLIS and PARIS - Medtronic, Inc., ...

Please provide your email address to receive an email when new articles are posted on . “Given that nivolumab [Opdivo, Bristol-Myers Squibb] works by releasing the brakes on the immune system, most ...

Sunitinib in papillary renal cell carcinoma (pRCC): Results from a single-arm phase II study. Background: With >5 yrs of clinical experience with SOR, a well-defined efficacy and safety profile has ...

July 8 (UPI) --In a move to improve kidney transplant equity, a new policy will remove a question about race from the Kidney Donor Profile Index because it "dishonors African American/Black donors." ...